California
On June 19, the Board of Pharmacy (Board) received notification from the Office of Administrative Law (OAL) that the Board's compounding regulation changes were approved. The Notice of Approval provides that the new regulations will become effective on October 1.
As required by law, the Board conducted a comprehensive review of its compounding regulations and identified necessary changes after United States Pharmacopoeia (USP) General Chapters became compendial. These efforts resulted in the Board voting, as part of its April 2023 Board meeting, to promulgate new regulations. Since that time, and after five formal comment periods, a regulation hearing and extensive review and discussion over the course of multiple public meetings, the Board completed the formal rulemaking process. With the recent approval by the OAL of the updated compounding regulations promulgated by the Board, the Board wishes to update its stakeholders on its policy related to licensees transitioning to the updated USP General Chapters and updated regulations.
During this intervening period, the Board encourages licensees to continue transitioning to the new standards established in USP and to take steps to establish compliance with the Board's updated regulations.
Source: View the policy statement. Revised July 28.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
